Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentric, Observational, Post-marketing, Registry Study to Assess the Correlation of High-resolution Specimen PET-CT Imaging, Using the XEOS AURA 10 PET-CT, With the Histopathology Results and Long-term Outcome of Patients Undergoing Resective Cancer Surgery.

NCT06970275 is registered in ClinicalTrials.gov with XEOS Medical as lead sponsor.

NCT NCT06970275
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06970275 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentric, Observational, Post-marketing, Registry Study to Assess the Correlation of High-resolution Specimen PET-CT Imaging, Using the XEOS AURA 10 PET-CT, With the Histopathology Results and Long-term Outcome of Patients Undergoing Resective Cancer Surgery.
Lead sponsor
XEOS Medical
Phase
Observational
Overall status
Recruiting
Start date
November 19, 2025
Completion date
January 15, 2031
Enrollment
850 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, cancer, head and neck cancer, prostate cancers